Target intelligence / Profile preview

Neisseria meningitidis Serogroup Y Polysaccharide Capsule (Serogroup Y Capsule)

Target
Serogroup Y Capsule
Molecular classification
Polysaccharide, Capsular Polysaccharide, Sialic Acid-containing Polysaccharide
01

Overview

The *Neisseria meningitidis* serogroup Y polysaccharide capsule is a surface-expressed carbohydrate structure that encapsulates the bacterium. It consists of repeating units of D-glucose and N-acetylneuraminic acid linked via α(2→6) glycosidic bonds. This capsule is a critical virulence factor, enabling the organism to evade host immune responses. It serves as the basis for serogroup classification and a key target for conjugate vaccines, such as MenACWY, providing protection against invasive meningococcal disease. Serogroup Y has become an increasingly important cause of invasive disease, including pneumonia, sepsis, and meningitis.

Other names
Group Y CapsuleNmY CapsuleSerogroup Y Polysaccharide
02

Mechanism of action

Antibodies targeting the capsule promote complement-mediated killing and/or opsonophagocytosis of *N. meningitidis*.

03

Biological functions

Immune evasionComplement resistancePhagocytosis inhibitionVirulence factorAntigen presentation (via vaccines)
04

Disease associations

Meningococcal diseaseMeningitisSepsisPneumonia
05

Safety considerations

Vaccine-related adverse events (rare)Potential for serogroup replacement following widespread vaccination
06

Interacting drugs

MenACWY vaccines (conjugated)

1 more in the full profile.

07

Biomarkers

Capsular polysaccharide detection in CSF or bloodAntibody titers against serogroup Y capsule (vaccine response)

Beyond the preview

Go deeper on Neisseria meningitidis Serogroup Y Polysaccharide Capsule (Serogroup Y Capsule).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neisseria meningitidis Serogroup Y Polysaccharide Capsule (Serogroup Y Capsule).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call